Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost-Effectiveness of Renin-Guided Treatment of Hypertension
Steven M. Smith, Jonathan D. Campbell
American Journal of Hypertension (2013) Vol. 26, Iss. 11, pp. 1303-1310
Open Access | Times Cited: 17

Showing 17 citing articles:

Prevalence and characteristics of low-renin hypertension in a primary care population
Sonali Shah, Renata Libianto, Stella May Gwini, et al.
Journal of the Endocrine Society (2024) Vol. 8, Iss. 8
Open Access | Times Cited: 5
Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario
E. Chowdhury, Christopher M. Reid, Ella Zomer, et al.
American Journal of Hypertension (2018) Vol. 31, Iss. 10, pp. 1156-1163
Open Access | Times Cited: 32
Renin and Aldosterone Measurements in the Management of Arterial Hypertension
A. Viola, Silvia Monticone, Jacopo Burrello, et al.
Hormone and Metabolic Research (2015) Vol. 47, Iss. 06, pp. 418-426
Open Access | Times Cited: 30
Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity
E. Chowdhury, Zanfina Ademi, John Moss, et al.
Medicine (2015) Vol. 94, Iss. 9, pp. e590-e590
Open Access | Times Cited: 19
Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men
Mohammadreza Amirsadri, Abbas Hassani
DARU Journal of Pharmaceutical Sciences (2015) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Care Management to Reduce Disparities and Control Hypertension in Primary Care
Jonathan Hong, William V. Padula, Ilene L. Hollin, et al.
Medical Care (2017) Vol. 56, Iss. 2, pp. 179-185
Closed Access | Times Cited: 11
Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
Mohammadreza Amirsadri, MohammadJavad Sedighi
Research in Pharmaceutical Sciences (2017) Vol. 12, Iss. 2, pp. 144-144
Open Access | Times Cited: 10
Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China
Leyi Liang, Taihang Shao, Hao Li, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Plasma Renin Testing to Guide Antihypertensive Therapy
Anthony J. Viera, Curt D. Furberg
Current Hypertension Reports (2014) Vol. 17, Iss. 1
Closed Access | Times Cited: 7
Effects of Blood Pressure Control in Cardiovascular Prevention
Nathan Artom, Alessandra Vecchié, Aldo Pende
Current Pharmaceutical Design (2016) Vol. 22, Iss. 37, pp. 5649-5661
Open Access | Times Cited: 5
Blood pressure telemonitoring and remote counseling in uncontrolled hypertension
М. V. Ionov, О. В. Жукова, Н. Э. Звартау, et al.
Terapevticheskii arkhiv (2021) Vol. 93, Iss. 1, pp. 30-40
Open Access | Times Cited: 4
Plasma Renin-guided Therapy in Patients of Primary Hypertension on Antihypertensives: A Prospective Cohort Study
M. Krishna Murty, Rajesh Pandey, Sibeka Behera, et al.
Journal of the Association of Physicians of India (2022) Vol. 70, Iss. 8, pp. 31-36
Open Access | Times Cited: 3
JNC 8: Shortcomings in Process and Treatment Recommendations
Curt D. Furberg, Michael H. Alderman
American Journal of Hypertension (2014) Vol. 27, Iss. 12, pp. 1443-1445
Open Access | Times Cited: 2
A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context
Lorenzo Pradelli, Giovanni Di Perri, Giuliano Rizzardini, et al.
Farmeconomia Health economics and therapeutic pathways (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control: A Pilot Study Utilizing a Smartphone App to Incorporate Plasma Renin Activity Testing
Mai Mehanna, Yiqing E. Chen, Yan Gong, et al.
Clinical and Translational Science (2020) Vol. 14, Iss. 2, pp. 617-624
Open Access | Times Cited: 1
4B.04
E. Chowdhury, Zanfina Ademi, John Moss, et al.
Journal of Hypertension (2015) Vol. 33, Iss. Supplement 1, pp. e53-e57
Open Access
Hipertensión arterial esencial: ¿cuál agente antihipertensivo elegir?
Nathalia Buitrago Gómez, Natalia Campo-Rivera, Lunevar Figueroa, et al.
Salud UIS (2022) Vol. 54, Iss. 1
Open Access
Page 1

Scroll to top